Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2015, Article ID 851046, 7 pages
http://dx.doi.org/10.1155/2015/851046
Case Report

Pulmonary Peripheral Carcinoids after Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Tumorlets: Report of 3 Cases

1Department of Anatomical Pathology, Hospital of the University of Coimbra (CHUC), Portugal
2Department of Anatomical Pathology, Portuguese Oncology Institute of Coimbra (IPOC), Portugal
3Department of Thoracic Surgery, Hospital of the University of Coimbra (CHUC), Portugal
4Institute of Anatomical Pathology and Molecular Pathology of the Medical Faculty of University of Coimbra (IAP-FMUC), Portugal

Received 19 August 2015; Accepted 8 October 2015

Academic Editor: Akif Turna

Copyright © 2015 Carlos Abrantes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Gorshtein, D. J. Gross, D. Barak et al., “Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors—clinical experience with a rare entity,” Cancer, vol. 118, no. 3, pp. 612–619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. N. Husain, “The lung; neuroendocrine proliferations and tumors,” in Robbins & Cotran Pathologic Basis of Disease, V. Kumar, A. K. Abbas, and J. C. Aster, Eds., p. 719, Saunders Elsevier, 9th edition, 2014. View at Google Scholar
  3. S. M. Aguayo, Y. E. Miller, J. A. Waldron Jr. et al., “Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease,” The New England Journal of Medicine, vol. 327, no. 18, pp. 1285–1288, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. “Tumours of the lung,” in WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, W. D. Travis, E. Brambilla, A. P. Burke, A. Marx, and A. G. Nicholson, Eds., pp. 73–79, International Agency for Research on Cancer, Lyon, France, 2015.
  5. 2015, http://www.chuc.min-saude.pt/.
  6. A. A. Nassar, D. E. Jaroszewski, R. A. Helmers, T. V. Colby, B. M. Patel, and F. Mookadam, “Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia—a systematic overview,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 1, pp. 8–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Davies, J. R. Gosney, D. M. Hansell et al., “Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease,” Thorax, vol. 62, no. 3, pp. 248–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. W. Koo, J. P. Baliff, D. A. Torigian, L. A. Litzky, W. B. Gefter, and S. R. Akers, “Spectrum of pulmonary neuroendocrine cell proliferation: diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids,” American Journal of Roentgenology, vol. 195, no. 3, pp. 661–668, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. D. Travis, “Advances in neuroendocrine lung tumors,” Annals of Oncology, vol. 21, supplement 7, pp. vii65–vii71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Wirtschafter, A. E. Walts, S. T. Liu, and A. M. Marchevsky, “Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia of the lung (DIPNECH): current best evidence,” Lung, vol. 193, no. 5, pp. 659–667, 2015. View at Publisher · View at Google Scholar
  11. G. Chassagnon, O. Favelle, S. Marchand-Adam, A. De Muret, and M. P. Revel, “DIPNECH: when to suggest this diagnosis on CT,” Clinical Radiology, vol. 70, no. 3, pp. 317–325, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Marchevsky, E. Wirtschafter, and A. E. Walts, “The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?” Human Pathology, vol. 46, no. 2, pp. 176–181, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. R. Miller and N. L. Muller, “Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors,” American Journal of Surgical Pathology, vol. 19, no. 6, pp. 653–658, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. D. R. A. Swarts, F. C. S. Ramaekers, and E.-J. M. Speel, “Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1826, no. 2, pp. 255–271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. D. Finkelstein, T. Hasegawa, T. Colby, and S. A. Yousem, “11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice,” The American Journal of Pathology, vol. 155, no. 2, pp. 633–640, 1999. View at Publisher · View at Google Scholar · View at Scopus